Kasenda, B., & Egerer, G. (2017). High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: A prospective multicentre trial by the German Cooperative PCNSL study group. Leukemia, 31(12), . https://doi.org/10.1038/leu.2017.170
Chicago Style (17th ed.) CitationKasenda, Benjamin, and Gerlinde Egerer. "High-dose Chemotherapy with Autologous Haematopoietic Stem Cell Support for Relapsed or Refractory Primary CNS Lymphoma: A Prospective Multicentre Trial by the German Cooperative PCNSL Study Group." Leukemia 31, no. 12 (2017). https://doi.org/10.1038/leu.2017.170.
MLA (9th ed.) CitationKasenda, Benjamin, and Gerlinde Egerer. "High-dose Chemotherapy with Autologous Haematopoietic Stem Cell Support for Relapsed or Refractory Primary CNS Lymphoma: A Prospective Multicentre Trial by the German Cooperative PCNSL Study Group." Leukemia, vol. 31, no. 12, 2017, https://doi.org/10.1038/leu.2017.170.